DNA-inorganic hybrid nanovaccine for cancer immunotherapy.
Zhu G, Liu Y, Yang X, Kim YH, Zhang H, Jia R, Liao HS, Jin A, Lin J, Aronova M, Leapman R, Nie Z, Niu G, Chen X.
Zhu G, et al.
Nanoscale. 2016 Mar 28;8(12):6684-92. doi: 10.1039/c5nr08821f.
Nanoscale. 2016.
PMID: 26947116
Free PMC article.